P3 Health Partners (NASDAQ:PIII) Price Target Lowered to $3.00 at TD Cowen

P3 Health Partners (NASDAQ:PIII) had its price objective dropped by equities researchers at TD Cowen from $8.00 to $3.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. TD Cowen’s target price indicates a potential upside of 11.52% from the company’s previous close.

A number of other research analysts have also recently weighed in on PIII. BTIG Research reiterated a “neutral” rating on shares of P3 Health Partners in a research report on Friday, December 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of P3 Health Partners in a research note on Thursday, January 22nd. Finally, Lake Street Capital cut their price target on shares of P3 Health Partners from $12.50 to $4.00 and set a “buy” rating on the stock in a report on Friday, March 27th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $3.50.

P3 Health Partners Price Performance

Shares of NASDAQ:PIII traded down $0.05 during trading on Thursday, hitting $2.69. The company had a trading volume of 433 shares, compared to its average volume of 83,924. The stock has a market cap of $19.39 million, a price-to-earnings ratio of -0.06 and a beta of 0.56. The company has a fifty day simple moving average of $2.47 and a two-hundred day simple moving average of $5.05. P3 Health Partners has a one year low of $1.52 and a one year high of $11.30.

P3 Health Partners (NASDAQ:PIII) last released its earnings results on Thursday, March 26th. The company reported ($23.02) earnings per share for the quarter, missing the consensus estimate of ($8.06) by ($14.96). The company had revenue of $384.81 million for the quarter, compared to the consensus estimate of $357.65 million. P3 Health Partners had a negative net margin of 10.14% and a negative return on equity of 302.33%. On average, equities research analysts anticipate that P3 Health Partners will post -0.67 earnings per share for the current year.

Institutional Investors Weigh In On P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC grew its holdings in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 26,678 shares of the company’s stock after acquiring an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned 0.37% of P3 Health Partners worth $239,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.75% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.